Bruce Robinson
Impact in
- Nephrology top 0.02%
- Dialysis and Renal Disease Management
- Parathyroid Disorders and Treatments
- Chronic Kidney Disease and Diabetes
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
- Nephrology 174
- Dialysis and Renal Disease Management 121
- Parathyroid Disorders and Treatments 37
- Chronic Kidney Disease and Diabetes 26
-
- Thyroid Cancer Diagnosis and Treatment 60
- Co-authors
- R. L. Pisoni (144 shared papers)Friedrich K. Port (63 shared papers)Francesca Tentori (41 shared papers)Brian A. Bieber (85 shared papers)Rajiv Saran (25 shared papers)Brenda W. Gillespie (24 shared papers)Hal Morgenstern (42 shared papers)Martin Jean Schlumberger (15 shared papers)
- Journals
- American Journal of Kidney Diseases (35 papers)Nephrology Dialysis Transplantation (30 papers)Clinical Journal of the American Society of Nephrology (19 papers)Kidney International (16 papers)Journal of the American Society of Nephrology (15 papers)
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Bruce Robinson
375 papers receiving 18.7k citations
Bruce Robinson's Hit Papers
Peers
Comparison fields: 5 of 193
- Nephrology 7.2k
- Endocrinology, Diabetes and Metabolism 4.5k
- Emergency Medical Services 1.3k
- Hematology 1.2k
- Transplantation 265
Countries citing papers authored by Bruce Robinson
This map shows the geographic impact of Bruce Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Robinson more than expected).
Fields of papers citing papers by Bruce Robinson
This network shows the impact of papers produced by Bruce Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Robinson. The network helps show where Bruce Robinson may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruce Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 383 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma Hit paper breakdown → | 2015 | 1648 |
| 2 | Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer Hit paper breakdown → | 2015 | 1549 |
| 3 | Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS) Hit paper breakdown → | 2008 | 847 |
| 4 | 2010 | 326 | |
| 5 | Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices Hit paper breakdown → | 2016 | 291 |
| 6 | 2013 | 288 | |
| 7 | 2013 | 271 | |
| 8 | Projecting ESRD Incidence and Prevalence in the United States through 2030 Hit paper breakdown → | 2018 | 261 |
| 9 | 2010 | 251 | |
| 10 | Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons Hit paper breakdown → | 2015 | 250 |
| 11 | 2014 | 234 | |
| 12 | 2014 | 210 | |
| 13 | 2017 | 202 | |
| 14 | 2015 | 197 | |
| 15 | Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 178 |
| 16 | 2014 | 171 | |
| 17 | 1998 | 167 | |
| 18 | 2004 | 163 | |
| 19 | 2020 | 154 | |
| 20 | 2010 | 151 |
About Bruce Robinson
Bruce Robinson is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism, Hematology, Emergency Medical Services and Pulmonary and Respiratory Medicine, having authored 383 papers that have together received 19.4k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (121 papers), Thyroid Cancer Diagnosis and Treatment (60 papers), Parathyroid Disorders and Treatments (37 papers), Erythropoietin and Anemia Treatment (27 papers), Chronic Kidney Disease and Diabetes (26 papers), Central Venous Catheters and Hemodialysis (22 papers), Iron Metabolism and Disorders (14 papers) and Potassium and Related Disorders (9 papers). The work is most often cited by research in Nephrology (7.2k citations), Endocrinology, Diabetes and Metabolism (4.5k citations), Emergency Medical Services (1.3k citations), Hematology (1.2k citations) and Transplantation (265 citations). Bruce Robinson has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include R. L. Pisoni, Friedrich K. Port, Francesca Tentori, Brian A. Bieber, Rajiv Saran, Brenda W. Gillespie, Hal Morgenstern, Martin Jean Schlumberger, Peter G. Kerr and Angelo Karaboyas. Their work appears in journals such as American Journal of Kidney Diseases, Nephrology Dialysis Transplantation, Clinical Journal of the American Society of Nephrology, Kidney International and Journal of the American Society of Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.